Type-I HTLV antibody in urban and rural Ghana, West Africa.
dc.contributor.author | Biggar, R.J. | |
dc.contributor.author | Saxinger, C. | |
dc.contributor.author | Gardiner, C. | |
dc.contributor.author | Collins, W.E. | |
dc.contributor.author | Levine, P.H. | |
dc.contributor.author | Clark, J.W. | |
dc.contributor.author | Nkrumah, F.K. | |
dc.contributor.author | Blattner, W.A. | |
dc.date.accessioned | 2013-06-12T11:46:29Z | |
dc.date.accessioned | 2017-10-16T12:58:02Z | |
dc.date.available | 2013-06-12T11:46:29Z | |
dc.date.available | 2017-10-16T12:58:02Z | |
dc.date.issued | 1984 | |
dc.description.abstract | The prevalence of antibodies against the newly described human T-cell lymphoma virus, type I (HTLV-I) in two communities in Ghana, West Africa, is described. There was no difference by community (urban, 3.6% and rural, 4.0%). Prevalence increased with age, being 5.9% among persons greater than 10 years old, but did not differ by sex. There was no difference when data were analysed by housing status or crowding. Non-confirmed reactions in the assay system were frequent and correlated with both prevalence and titer of antibody against malaria. Possible explanations include vector-borne transmission like that of malaria, but the relationship is more probably due to a polyclonal stimulation of B cells, enhancing the potential for detecting reactivity in the assay. Because assay systems vary and because most laboratories do not routinely use a confirmation assay, results presented by different groups must be interpreted cautiously. | en_US |
dc.identifier.citation | Biggar, R. J., Saxinger, C., Gardiner, C., Collins, W. E., Levine, P. H., Clark, J. W., . . . Blattner, W. A. (1984). Type-I HTLV antibody in urban and rural Ghana, West Africa. International Journal of Cancer, 34(2), 215-219. | en_US |
dc.identifier.uri | http://197.255.68.203/handle/123456789/3089 | |
dc.language.iso | en | en_US |
dc.publisher | International Journal of Cancer | en_US |
dc.subject | Adolescent | en_US |
dc.subject | Adult | en_US |
dc.subject | Age factors | en_US |
dc.subject | Antibodies | en_US |
dc.subject | Child | en_US |
dc.subject | Child, preschool | en_US |
dc.subject | Deltaretrovirus | en_US |
dc.subject | Female | en_US |
dc.subject | Ghana | en_US |
dc.subject | Herpes virus 4 | en_US |
dc.subject | Humans | en_US |
dc.subject | Infant | en_US |
dc.subject | Male | en_US |
dc.subject | Plasmodium falciparum | en_US |
dc.subject | Retroviridae infections | en_US |
dc.subject | Rural population | en_US |
dc.subject | Socio-economic factors | en_US |
dc.subject | Urban population | en_US |
dc.title | Type-I HTLV antibody in urban and rural Ghana, West Africa. | en_US |
dc.type | Article | en_US |